Chemical drug research and developΩ↔≥ment

Key words:

Products News Download

Glorious Moment丨Haibu Pharmaceutical α✘​has received multiple honors!


Beijing Haibu Pharmace₽β≈>utical Technology Co., Ltd. has bδ∑een honored as one of thα‍Ωe "Top 50 R&D Companies ∞ in the Pharmaceutic€↔$ al Industry for 2023-2024&q→Ω✔$uot;, marking another co•≈nsecutive year for Haibu Ph©∞↔♠armaceutical to receive this ac♥≥♦>colade.

【Announcement】Beijing Haibu Pharmac©≈eutical Technology Co.>₽, Ltd. Hazardous Waste Pollution Prev<≈ention and Control Information≈Ω♣↓ Announcement


According to the requ₽αirements of the "Law of the Pe€↓ople's Republic of ‌σ✘λChina on the Preventio•Ω←±n and Control of Environment¶&β≈al Pollution by Solid Waste&q£★ uot;, units that generate solid ÷™γ£waste shall timely disclose i​λnformation on solid waste pollut↑∏±§ion to the environment in accordan"$♦ce with the law and activel÷ y accept social superv♥‍βision.

【Good News】Haibu Pharmaceuti↕∑€cal's Riluzole raw material'≥₽‌ has obtained the FDA regis™‌∏ tration number in the Un&☆←ited States.


Our company has a wide variety≥♥ of raw materials with sta>✘±ble supply. Welcome to inquire. Mr♦β. Wei: 18515385101; Mr. Wu: 1560<∏↔0038801

【Good News】Haibu Pharmaceutical&#♠↕♦βx27;s Riluzole Tablets (40m₹₽βg) have obtained clinical trial appr•≥λoval.


Introduction: The indications≈≤Ω are to improve the following sy§∏♣εmptoms of uterine fibroi¥πds (excessive menstrσ®←‍uation, lower abdominal pa↔×"‌in, back pain, anemia); to€÷ alleviate the pain of endometriosis.★•

【Good News】Haibu Pharmaceutical'γ★&;s pregabalin oral so↕ lution has obtained a produc★©×tion license.


Pregabalin oral solution has oδ‍btained production approval☆Ω [National Drug Standard H20244‍β981], used for the treat★↔ment of postherpetic neuralgia; fibrom₹←σ↓yalgia; and as an adjunctγΩ®™ive treatment for partial seizures in €₩±adults.

How to choose a suitable for yβγou?

Let us assist you!

Our experts will contact youε÷ as soon as possible to meet your needsΩ Ωγ.